150 filings
Page 5 of 8
SC 13G
Crossover Capital Fund I, LLC
2 Mar 18
Reign Sapphire Corp
12:00am
8-K
SIGY
Sigyn Therapeutics, Inc.
23 Feb 18
Entry into a Material Definitive Agreement
12:00am
SC 13G/A
Brio Capital Master Fund Ltd.
26 Jan 18
Reign Sapphire Corp
12:00am
8-K
SIGY
Sigyn Therapeutics, Inc.
8 Jan 18
Entry into a Material Definitive Agreement
12:00am
D/A
SIGY
Sigyn Therapeutics, Inc.
16 Nov 17
$1.25M in equity / debt / options / securities to be acquired, sold $1.25M, 2 investors
12:00am
8-K
SIGY
Sigyn Therapeutics, Inc.
16 Nov 17
Entry into a Material Definitive Agreement
12:00am
10-Q
2017 Q3
SIGY
Sigyn Therapeutics, Inc.
Quarterly report
13 Nov 17
12:00am
8-K
SIGY
Sigyn Therapeutics, Inc.
5 Sep 17
Regulation FD Disclosure
12:00am
10-Q
2017 Q2
SIGY
Sigyn Therapeutics, Inc.
Quarterly report
14 Aug 17
12:00am
8-K/A
SIGY
Sigyn Therapeutics, Inc.
7 Aug 17
Index to Financial Statements
12:00am
8-K
SIGY
Sigyn Therapeutics, Inc.
3 Jul 17
Entry into a Material Definitive Agreement
12:00am
4/A
Joseph Segelman
27 Jun 17
Reign Sapphire / Joseph Segelman ownership change
12:00am
4
SIGY
Sigyn Therapeutics, Inc.
23 Jun 17
Reign Sapphire / Joseph Segelman ownership change
12:00am
424B3
SIGY
Sigyn Therapeutics, Inc.
2 Jun 17
Prospectus supplement
12:00am
10-Q
2017 Q1
SIGY
Sigyn Therapeutics, Inc.
Quarterly report
2 Jun 17
12:00am
424B3
SIGY
Sigyn Therapeutics, Inc.
2 Jun 17
Prospectus supplement
12:00am
10-K/A
2016 FY
SIGY
Sigyn Therapeutics, Inc.
Annual report (amended)
31 May 17
12:00am
10-K
2016 FY
SIGY
Sigyn Therapeutics, Inc.
Annual report
31 May 17
12:00am
8-K
SIGY
Sigyn Therapeutics, Inc.
31 May 17
Entry into a Material Definitive Agreement
12:00am
8-K
SIGY
Sigyn Therapeutics, Inc.
24 May 17
Material Modifications to Rights of Security Holders
12:00am